Checklist can guide Australian govt on PBS policy
Australia's Pharmaceutical Benefits Scheme continues in the spotlight, since a recent report from the country's Pharmacy Guild revealed that it could save the government some A$7.4 billion ($5.3 billion) over 10 years (Marketletter April 20).
Pharmaceutical industry body Medicines Australia chief executive Ian Chalmers proposed a four-step checklist for the government to use for any future policy decisions for the PBS. Speaking at the Future of the PBS conference in Sydney, Mr Chalmers told health industry experts that the government should ask itself four key questions in framing future policy decisions for the PBS.
The key questions are:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze